wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35759609-4AB007C8-FF24-41A9-B4C2-DA62C77889B2
Q35759609-4AB007C8-FF24-41A9-B4C2-DA62C77889B2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35759609-4AB007C8-FF24-41A9-B4C2-DA62C77889B2
Initial therapy for human immunodeficiency virus: broadening the options.
P2860
Q35759609-4AB007C8-FF24-41A9-B4C2-DA62C77889B2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35759609-4AB007C8-FF24-41A9-B4C2-DA62C77889B2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9ea2051e0f1ef18d8848ec0102c192d7a403a793
P2860
Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects.